The WHO has sought “additional clarifications" from Bharat Biotech for Covaxin to conduct a final risk-benefit assessment for Emergency Use Listing of the vaccine.
from Top India News- News18.com https://ift.tt/3w26gfu
via IFTTT
from Top India News- News18.com https://ift.tt/3w26gfu
via IFTTT
Comments
Post a Comment
dipakvparmar1979@gmail.com